Patent Application
Provisional
App. No. 60/311,115
· Confirmation No. 4031
Methods and compounds for disruption of CD40/CD40L signaling in the treatment of alzheimer's disease
Provisional Application Expired
Inventors
Prosecution
- Docket No.
- 114205.3400
- Confirmation No.
- 4031
Child
Claims priority from a provisional application
→
App. 12/604,545
Filed 2009-10-23
· Abandoned -- Incomplete Application (Pre-examination)
Child
PCT
Claims priority from a provisional application
→
PCT/US2002/027035
Filed 2002-08-12
· PCT - IPER (International Preliminary Examination Report) 409-416 Mailed
Child
Claims priority from a provisional application
→
App. 10/218,004
Filed 2002-08-12
· Abandoned -- Failure to Respond to an Office Action
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 60/311,115
- Filed
- 2001-08-10
External Links